| Financial Year |
March 31 2023 |
| Monetary Funds |
807,038,709.54 |
| Held-for-trading Financial Assets |
68,700.00 |
| Notes Receivable |
6,567,555.15 |
| Accounts Receivable |
501,868,692.32 |
| Advances to Suppliers |
8,349,589.89 |
| Other Receivables |
441,233,213.31 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
65,000.00 |
| Dividend Receivable |
-- |
| Inventories |
480,085,153.78 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
735,144.95 |
| Other Current Assets |
42,399,463.30 |
| Total Current Assets |
2,426,519,623.37 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
1,924,284.48 |
| Long-term Equity Investment |
-- |
| Investment Properties |
97,073,808.84 |
| Fixed Assetes |
2,215,775,103.93 |
| Under-construction Projects |
64,179,844.48 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
69,438,740.75 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
138,562,447.12 |
| Deferred Income Tax Assets |
133,948,675.10 |
| Other Non-Current Assets |
5,010,211.28 |
| Sub-Total of Non-Current Assets |
2,735,015,212.30 |
| Total Assets |
5,161,534,835.67 |
| Short-Term Loans |
302,344,220.39 |
| Trading Financial liabilities |
44,200.00 |
| Notes Payable |
244,071,700.79 |
| Accounts Payable |
584,004,270.37 |
| Accounts Received In Advance |
1,381,491.85 |
| Employee Compensation Payable |
51,606,280.05 |
| Taxes Payable |
8,754,372.42 |
| Interest Payable |
934,406.80 |
| Dividend Payable |
-- |
| Other payables |
176,383,080.06 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
5,615,583.35 |
| Other Current Liabilities |
10,520,300.39 |
| Sub-Total of Current Liabilities |
1,386,513,894.50 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
52,052,445.43 |
| Special Payable |
-- |
| Estimatied Liabilities |
6,425,841.29 |
| Deferred Income Tax Liabilities |
92,558,664.96 |
| Other Non-Current Liabilities |
100,000,000.00 |
| Sub-Total of Non-Current Liabilities |
345,326,914.22 |
| Total Liabilities |
1,731,840,808.72 |
| Paid-In Capital(Or Share Stock) |
4,170,293,287.00 |
| Capital Surplus |
5,228,697,808.40 |
| Surplus Reserve |
15,471,983.67 |
| LESS:Treasury Stock |
196,513,827.00 |
| Undistributed Profits |
-5,351,017,753.93 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,429,694,026.95 |
| Owner's Equity（Stockholder's Equity） |
3,429,694,026.95 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,161,534,835.67 |
